Versant Venture Management, LLC Portfolio Holdings

Versant Venture Management, LLC

  • $56.3 Million
  • Q2 2025

Versant Venture Management, LLC has filed its 13F form on August 11, 2025 for Q2 2025 where it was disclosed a total value porftolio of $56.3 Million distributed in 8 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Monte Rosa Therapeutics, Inc. with a value of $25.5M, Crispr Therapeutics Ag with a value of $24.2M, Repare Therapeutics Inc. with a value of $3.68M, Tempest Therapeutics, Inc. with a value of $1.83M, and Adverum Biotechnologies, Inc. with a value of $1.09M.

Examining the 13F form we can see an increase of $8.32M in the current position value, from $48M to 56.3M.

Versant Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about Versant Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $56.3 Million
Healthcare: $56.3 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.42B
$24.2 Million 43.04% of portfolio
498,558
Q3 2021 Reduced 1.97%

Summary

  • Portfolio
  • No. of Stocks 8
  • Current Value $56.3 Million
  • Prior Value $48 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 11, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 2 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Versant Venture Management, LLC Portfolio

Follow Versant Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Versant Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email